80
Baylor Scott & White Heart and Vascular Hospital | Clinical Trials and Research
VAREE - The variability of donor-derived cellfree DNA after heart transplantation . Principal investigator : Timothy Gong , MD .
VASCC PROJECT 2 - The study will look at various outcomes , including but not limited to in-hospital complications and adverse events related to the patterns of hematologic changes among COVID-19 patients . The study will also aim to identify various management practices among a diverse group of vascular surgeons around the world and correlate with patient outcomes . Principal investigator : John Eidt , MD .
VT-PAS - FlexAbility SE catheter post approval study . Principal investigator : Praveen Rao , MD .
VT REGISTRY - A retrospectice V-tach ablations outcomes study . Principal investigator : Praveen Rao , MD .
WAVE - A prospective , randomized , controlled , multicenter study comparing the Merit WRAPSODY endovascular stent graft to percutaneous transluminal angioplasty for treatment of venous outflow circuit stenosis or occlusion in hemodialysis patients . Principal investigator : Stephen Hohmann , MD .
XLCAD REGISTRY - Database for coronary interventions , very similar to XLPAD just for the coronary arteries instead of peripheral . Split into two sections : left main and non-left main interventions . Principal investigator : Subhash Banerjee , MD .
XLPAD-GE - Evaluation of cardiorenal and limb outcomes of patients undergoing endovascular revascularization using contemporary strategies , techniques and devices in the multicenter . Principal investigator : Subhash Banerjee , MD .
XLPAD REGISTRY - Multi-center registry for peripheral arterial disease interventions and outcomes . Principal investigator : Subhash Banerjee , MD .
XLPAD ANGIOSAFE - Comparative outcomes of interventions for femoropopliteal and below the knee occlusions : insights form the XLPAD Registry . Principal investigator : Subhash Banerjee , MD .
XLPAD ABBOTT - Outcomes of below the knee balloon angioplasty percutaneous interventions : Insights from the XLPAD Registry . Principal investigator : Subhash Banerjee , MD .
Baylor Scott & White Research Institute — Fort Worth site
ADVANCE LAA – A real-world study to observe outcomes of patients undergoing closure with the Amplatzer Amulet left atrial appendage occluder . Principal investigator : Aleem Mughal , MD .
AIM HIGHER – Assessment of implantable cardiac contractility modulation ( CCM ) in the heart failure group with higher ejection fraction . This study aims to evaluate the efficacy and safety of CCM therapy in patients with symptomatic heart failure and ejection fraction in the range of 40 to 60 %. Principal investigator : Aleem Mughal , MD .
CATALYST – A clinical trial of atrial fibrillation patients to evaluate the safety and effectiveness of the Amulet device compared to NOAC therapy in patients with non-valvular atrial fibrillation at increased risk of ischemic stroke who are recommended for long-term NOAC therapy . Principal investigator : Scott Ewing , DO .
CV UMBRELLA - Umbrella protocol for retrospective CV research on the Fort Worth campus . Principal investigators : Anita Krueger , MD , and Salman Gohar , MD .
INTERMACS - The Intermacs registry is a national quality improvement system designed to advance the understanding and application of mechanical circulatory support in order to improve the duration and quality of life in patients with advanced heart failure . Lead investigator for Fort Worth : Salman Gohar , MD .
LEAAAPS - Left atrial appendage exclusion for prophylactic stroke reduction trial . Lead investigator for Fort Worth : Anita Krueger , MD .
LIBREXIA AF - A Phase 3 randomized , double-blind , double-dummy , parallel group , active controlled study to evaluate the efficacy and safety of an oral factor Xla inhibitor vs Apixaban in subjects with atrial fibrillation . Principal investigator : Mohanakrishnan Sathyamoorthy , MD .
LIFE-BTK - Clinical trial to evaluate the safety and effectiveness of the new Esprit below-the-knee ( BTK ) everolimus-eluting resorbable scaffold system . Principal investigator : Katherine Kane , MD .